The Institute for Animal Health (IAH)
MetadataShow full item record
CTA. 1994. The Institute for Animal Health (IAH). Spore 50. CTA, Wageningen, The Netherlands.
Permanent link to this item: http://hdl.handle.net/10568/49380
The Institute for Animal Health (IAH)The UK-based Institute for Animal Health (IAH) is one of the world's leading centres for animal disease research. Its interests include many of the diseases which are of significance to ACP countries. Its main...
The UK-based Institute for Animal Health (IAH) is one of the world's leading centres for animal disease research. Its interests include many of the diseases which are of significance to ACP countries. Its main base at Compton is supported by a laboratory in Surrey working with exotic infectious diseases and a unit in Edinburgh working on the spongiform encephalopathies, such as BSE. Over the past 60 years IAH has built up scientific knowledge and expertise on most important animal diseases. The Institute has a range of animals of known health status and genetic background including two dairy herds, three sheep flocks, a herd of dwarf pigs, 14 strains of specific pathogen free (SPF) poultry and 14 strains of SPF mice. The health status ranges from specific pathogen free animals to minimal disease and conventional animals. IAH's unique facilities and scientific capabilities make research from the single gene through to the whole animal possible. The institute has four divisions: immunology and pathology, epidemiology, molecular biology and environmental microbiology. IAH aims to advance scientific knowledge of the major farm animal diseases and has an international lead in many of its research programmes. The Institute also has important international responsibilities such as providing reference diagnostic facilities for foot and mouth disease virus (FMDV) and rinderpest (it maintains emergency vaccine banks for FMDV). IAH supplies rinderpest vaccine to control outbreaks and a seed virus to vaccine laboratories throughout Asia and Africa. It plays a leading role in the Pan African Rinderpest Campaign. A new live capripox/rinderpest vaccine developed by IAH is proving highly effective in controlled trials in Kenya. This very stable vaccine can be freeze-dried and re-constituted on site. Simple-to-use FMDV detection kits have been developed and are distributed world-wide. Part of the Institute's role as a World and EC Reference Laboratory is to carry out and standardize diagnostic tests and also to supply reagents for diagnostic kits world-wide. At short notice the IAH laboratory can provide at least half a million doses of fully formulated vaccine of each of six strains of FMDV antigens. The Institute is also designated as the FAO Regional Centre for bluetongue, rinderpest, peste des petite ruminants and African Horse sickness. As an OIE Reference Laboratory for Marek's Disease of poultry, lAH's responsibilities include providing standard strains of the virus, diagnostic standards, collecting and processing data and providing training. Training in diagnostic methods is provided by IAH as part of the Pan African Rinderpest Campaign. It supplies all rinderpest ELISA kits for the 28 African countries that are part of the Campaign and demand for the kits is still increasing. Other recent examples of technology transfer are the commercialization of vaccines against coccidiosis in poultry, and respiratory syncytial disease and mucosal disease in cattle. IAH has a specialist animal health library, available to bona fide scientists by prior arrangement. It also runs an abstract service for exotic diseases and information service. Copies of lAH's annual report are available from the Institute. Institute of Aoimal Health Compton Newbury Berkshire RG 16 ONN UK